Influx Healthtech IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Jun 18 to Jun 20 2025
Price Band
₹96
Current GMP
₹132.5(38.02%)
Subscription
201.35 times
IPO Details
| IPO Date | June 18, 2025 to June 20, 2025 |
| Listing Date | June 25, 2025 |
| Face Value | ₹10 per share |
| Issue Price | ₹96 per share |
| Lot Size | 1,200 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 61,00,800 shares (aggregating up to ₹58.57 Cr) |
| Reserved for Market Maker | 3,06,000 shares (aggregating up to ₹2.94 Cr)R.K.Stock Holding Private Limited |
| Fresh Issue (Ex Market Maker) | 46,94,400 shares (aggregating up to ₹45.07 Cr) |
| Offer for Sale (Ex Market Maker) | 11,00,400 shares of ₹10 (aggregating up to ₹10.56 Cr) |
| Net Offered to Public | 57,94,800 shares (aggregating up to ₹55.63 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,81,50,000 shares |
| Share Holding Post Issue | 2,31,50,400 shares |
IPO Date
June 18, 2025 to June 20, 2025
Listing Date
June 25, 2025
Face Value
₹10 per share
Issue Price
₹96 per share
Lot Size
1,200 Shares
Sale Type
Fresh Capital-cum-Offer for Sale
Total Issue Size
61,00,800 shares (aggregating up to ₹58.57 Cr)
Reserved for Market Maker
3,06,000 shares (aggregating up to ₹2.94 Cr)R.K.Stock Holding Private Limited
Fresh Issue (Ex Market Maker)
46,94,400 shares (aggregating up to ₹45.07 Cr)
Offer for Sale (Ex Market Maker)
11,00,400 shares of ₹10 (aggregating up to ₹10.56 Cr)
Net Offered to Public
57,94,800 shares (aggregating up to ₹55.63 Cr)
Issue Type
Bookbuilding IPO
Listing At
NSE SME
Share Holding Pre Issue
1,81,50,000 shares
Share Holding Post Issue
2,31,50,400 shares
IPO Subscription Details
| Anchor Investors | 1 |
| Market Maker | 1 |
| Qualified Institutions | 137.87 |
| Non-Institutional Buyers*** | 481.10 |
| Retail Investors | 117.68 |
| Total ** | 201.35 |
Anchor Investors
1
Market Maker
1
Qualified Institutions
137.87
Non-Institutional Buyers***
481.10
Retail Investors
117.68
Total **
201.35
Day Wise Sub
| Day | QIB | NII* | Retail | Total |
|---|---|---|---|---|
| Day 1 Jun 18, 2025 | 1.46 | 5.81 | 8.46 | 5.89 |
| Day 2 Jun 19, 2025 | 1.69 | 32.28 | 36.13 | 25.47 |
| Day 3 Jun 20, 2025 | 137.87 | 481.10 | 117.68 | 201.35 |
DayDay 1
Jun 18, 2025
QIB1.46
NII*5.81
Retail8.46
Total5.89
DayDay 2
Jun 19, 2025
QIB1.69
NII*32.28
Retail36.13
Total25.47
DayDay 3
Jun 20, 2025
QIB137.87
NII*481.10
Retail117.68
Total201.35
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 25-06-2025 | 96.00 | 20(20.83%) | 116 |
| 24-06-2025 | 96.00 | 20(20.83%) | 116 |
| 23-06-2025 | 96.00 | 17(17.71%) | 113 |
| 22-06-2025 | 96.00 | 22(22.92%) | 118 |
| 21-06-2025 | 96.00 | 22(22.92%) | 118 |
| 20-06-2025 | 96.00 | 22(22.92%) | 118 |
| 19-06-2025 | 96.00 | 38(39.58%) | 134 |
| 18-06-2025 | 96.00 | 45(46.88%) | 141 |
| 17-06-2025 | 96.00 | 40(41.67%) | 136 |
| 16-06-2025 | 96.00 | 40(41.67%) | 136 |
| 15-06-2025 | 96.00 | 35(36.46%) | 131 |
| 14-06-2025 | 96.00 | 31(32.29%) | 127 |
| 13-06-2025 | 96.00 | 24(25.00%) | 120 |
| 12-06-2025 | 96.00 | 20(20.83%) | 116 |
Date25-06-2025
Price96.00
GMP20(20.83%)
Estimate List Price116
Date24-06-2025
Price96.00
GMP20(20.83%)
Estimate List Price116
Date23-06-2025
Price96.00
GMP17(17.71%)
Estimate List Price113
Date22-06-2025
Price96.00
GMP22(22.92%)
Estimate List Price118
Date21-06-2025
Price96.00
GMP22(22.92%)
Estimate List Price118
Date20-06-2025
Price96.00
GMP22(22.92%)
Estimate List Price118
Date19-06-2025
Price96.00
GMP38(39.58%)
Estimate List Price134
Date18-06-2025
Price96.00
GMP45(46.88%)
Estimate List Price141
Date17-06-2025
Price96.00
GMP40(41.67%)
Estimate List Price136
Date16-06-2025
Price96.00
GMP40(41.67%)
Estimate List Price136
Date15-06-2025
Price96.00
GMP35(36.46%)
Estimate List Price131
Date14-06-2025
Price96.00
GMP31(32.29%)
Estimate List Price127
Date13-06-2025
Price96.00
GMP24(25.00%)
Estimate List Price120
Date12-06-2025
Price96.00
GMP20(20.83%)
Estimate List Price116
IPO Important Dates
| IPO Open Date | Wed, Jun 18, 2025 |
| IPO Close Date | Fri, Jun 20, 2025 |
| Tentative Allotment | Mon, Jun 23, 2025 |
| Initiation of Refunds | Tue, Jun 24, 2025 |
| Credit of Shares to Demat | Tue, Jun 24, 2025 |
| Tentative Listing Date | Wed, Jun 25, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on June 20, 2025 |
IPO Open Date
Wed, Jun 18, 2025
IPO Close Date
Fri, Jun 20, 2025
Tentative Allotment
Mon, Jun 23, 2025
Initiation of Refunds
Tue, Jun 24, 2025
Credit of Shares to Demat
Tue, Jun 24, 2025
Tentative Listing Date
Wed, Jun 25, 2025
Cut-off time for UPI mandate confirmation
5 PM on June 20, 2025
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1200 | ₹1,15,200 |
| Retail (Max) | 1 | 1200 | ₹1,15,200 |
| HNI (Min) | 2 | 2,400 | ₹2,30,400 |
ApplicationRetail (Min)
Lots1
Shares1200
Amount₹1,15,200
ApplicationRetail (Max)
Lots1
Shares1200
Amount₹1,15,200
ApplicationHNI (Min)
Lots2
Shares2,400
Amount₹2,30,400
Financial Information
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 70.30 | 41.10 | 28.30 |
| Revenue | 104.99 | 100.10 | 76.07 |
| Profit After Tax | 13.37 | 11.22 | 7.20 |
| Net Worth | 36.15 | 22.87 | 11.65 |
| Reserves and Surplus | 18.00 | 22.85 | 11.63 |
| Total Borrowing | 0.22 | 0.32 | 0.80 |
Period EndedPeriod Ended
31 Mar 202531 Mar 2025
31 Mar 202431 Mar 2024
31 Mar 202331 Mar 2023
Period EndedAssets
31 Mar 202570.30
31 Mar 202441.10
31 Mar 202328.30
Period EndedRevenue
31 Mar 2025104.99
31 Mar 2024100.10
31 Mar 202376.07
Period EndedProfit After Tax
31 Mar 202513.37
31 Mar 202411.22
31 Mar 20237.20
Period EndedNet Worth
31 Mar 202536.15
31 Mar 202422.87
31 Mar 202311.65
Period EndedReserves and Surplus
31 Mar 202518.00
31 Mar 202422.85
31 Mar 202311.63
Period EndedTotal Borrowing
31 Mar 20250.22
31 Mar 20240.32
31 Mar 20230.80
IPO Reservation
| Market Maker Shares Offered | 3,06,000 (4.78%) |
| QIB Shares Offered | 28,95,600 (45.20%) |
| Anchor Investor Shares Offered | 17,36,400 (27.10%) |
| QIB (Ex. Anchor) | 11,59,200 (18.09%) |
| NII (HNI) Shares Offered | 8,70,000 (13.58%) |
| Retail Shares Offered | 20,29,200 (31.67%) |
| Total Shares Offered | 64,06,800 (100.00%) |
Market Maker Shares Offered
3,06,000 (4.78%)
QIB Shares Offered
28,95,600 (45.20%)
Anchor Investor Shares Offered
17,36,400 (27.10%)
QIB (Ex. Anchor)
11,59,200 (18.09%)
NII (HNI) Shares Offered
8,70,000 (13.58%)
Retail Shares Offered
20,29,200 (31.67%)
Total Shares Offered
64,06,800 (100.00%)
Information about company
Incorporated in September 2020, Influx Healthtech Limited is a healthcare-focused company specialising in contract manufacturing. The company is a reliable CDMO, providing specialized services to clients in multiple industries.
The company has three manufacturing facilities in Thane, Maharashtra, each covering an area of 9,676 square feet, 13,000 square feet, and 14,000 square feet, respectively.
Product Portfolio:
Tablets, Capsules, and Powders
Liquid Orals and Softgels
Lozenges, Jellies, and Gummies
Oral Dispersible Films (ODFs)
Effervescent Tablets and Liquid-Fill Capsules
Candies and Gym/Sports Supplements
Skin Care and Body Care Products
Hair Care and Beard Care Solutions
Face Masks and Soaps.
Ayurvedic / Herbal formulations
Veterinary Feed Supplements
Homecare solutions
The Company aids Nutraceutical and Cosmetic firms with product development and manufacturing. It offers end-to-end services, including development, production, and regulatory support, enabling clients to focus on formulation and commercialization.
As of June 11, 2025, the company has 163 permanent employees on a payroll basis.
Competitive Strength
Diversified Product Portfolio
Diverse Clientele
Stringent Quality Assurance/Quality Control
Experienced and Qualified Promoters and Management team.
Objectives of IPO
The Company Influx Healthtech IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
S.No.
Objects of the Issue
Expected Amount (Rs. in crores)
1
Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division
22.60
2
Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division
11.59
3
Purchase of Machineries for Homecare and Cosmetic Division
2.76
4
General corporate purposes
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App